Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
April 25, 2008
The role of hepatic transporters in drug elimination
Christoph Funk
Archives of Toxicology
|
October 22, 2016
Current limitations and future opportunities for prediction of DILI from in vitro
Christoph Funk, Adrian Roth
Journal of Pharmaceutical Sciences
|
March 24, 2010
Extrapolating in vitro metabolic interactions to isolated perfused liver: predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine
Sami Haddad, Patrick Poulin, Christoph Funk
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 2, 2014
Response to "Breast cancer resistance protein substrate and inhibition evaluation: why, when, and how?"
Agnès Poirier, Mohammed Ullah, Christoph Funk
Plos One
|
August 14, 2024
Finding common development paths in voluntary national reviews reporting on sustainable development goals using aspect-based sentiment analysis
Christoph Funk, Elena Tönjes, Ramona Teuber, et al.
Plos One
|
November 2, 2023
Evaluating TCFD reporting-A new application of zero-shot analysis to climate-related financial disclosures
Alix Auzepy, Elena Tönjes, David Lenz, et al.
Current Opinion in Drug Discovery & Development
|
February 3, 2007
New strategies to address drug-drug interactions involving OATPs
Agnés Poirier, Christoph Funk, Thierry Lavé, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 2, 2007
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
Johannes Noé, Renée Portmann, Marie-Elise Brun, et al.
Chemistry & Biodiversity
|
November 26, 2009
Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data
Agnès Poirier, Anne-Christine Cascais, Christoph Funk, et al.
Molecular Pharmaceutics
|
September 11, 2009
Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine
Agnès Poirier, Christoph Funk, Jean-Michel Scherrmann, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Expert Opinion on Drug Metabolism & Toxicology
|
April 25, 2008
The role of hepatic transporters in drug elimination
Christoph Funk
Archives of Toxicology
|
October 22, 2016
Current limitations and future opportunities for prediction of DILI from in vitro
Christoph Funk, Adrian Roth
Journal of Pharmaceutical Sciences
|
March 24, 2010
Extrapolating in vitro metabolic interactions to isolated perfused liver: predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine
Sami Haddad, Patrick Poulin, Christoph Funk
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 2, 2014
Response to "Breast cancer resistance protein substrate and inhibition evaluation: why, when, and how?"
Agnès Poirier, Mohammed Ullah, Christoph Funk
Plos One
|
August 14, 2024
Finding common development paths in voluntary national reviews reporting on sustainable development goals using aspect-based sentiment analysis
Christoph Funk, Elena Tönjes, Ramona Teuber, et al.
Plos One
|
November 2, 2023
Evaluating TCFD reporting-A new application of zero-shot analysis to climate-related financial disclosures
Alix Auzepy, Elena Tönjes, David Lenz, et al.
Current Opinion in Drug Discovery & Development
|
February 3, 2007
New strategies to address drug-drug interactions involving OATPs
Agnés Poirier, Christoph Funk, Thierry Lavé, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 2, 2007
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
Johannes Noé, Renée Portmann, Marie-Elise Brun, et al.
Chemistry & Biodiversity
|
November 26, 2009
Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data
Agnès Poirier, Anne-Christine Cascais, Christoph Funk, et al.
Molecular Pharmaceutics
|
September 11, 2009
Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine
Agnès Poirier, Christoph Funk, Jean-Michel Scherrmann, et al.
Page
of 5